Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571733
Study on the Efficacy of Spinal Cord Stimulation in Patients With Severe Refractory Primary or Secondary RLSClinica ARS MedicaNot Yet RecruitingNot Applicable
NCT07571733Not Yet Recruiting
Not Applicable
Study on the Efficacy of Spinal Cord Stimulation in Patients With Severe Refract...Clinica ARS Medica
NCT07569237
Patient-Reported Outcomes of Four Intraoral Suture MaterialsJordan University HospitalNot Yet RecruitingNot Applicable
NCT07569237Not Yet Recruiting
Not Applicable
Patient-Reported Outcomes of Four Intraoral Suture MaterialsJordan University Hospita...
NCT07570576
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hong KongNot Yet RecruitingNot Applicable
NCT07570576Not Yet Recruiting
Not Applicable
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hon...
NCT07571837
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical TrialAl-Azhar UniversityRecruitingNot Applicable
NCT07571837Recruiting
Not Applicable
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication...Al-Azhar University
NCT07570043
A Study to Evaluate the Efficacy of a Postbiotic Supplement on Menopausal Symptoms in Premenopausal WomenAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07570043Active Not Recruiting
Not Applicable
A Study to Evaluate the Efficacy of a Postbiotic Supplement on Menopausal Sympto...Able Biolabs, LLC
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07570927
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine UseMasaryk UniversityCompletedNot Applicable
NCT07570927Completed
Not Applicable
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine Us...Masaryk University
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07569770
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Composition and Performance in Elite Rugby PlayersUniversity of TaipeiCompletedNot Applicable
NCT07569770Completed
Not Applicable
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Com...University of Taipei
NCT07569328
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen HospitalNot Yet RecruitingNot Applicable
NCT07569328Not Yet Recruiting
Not Applicable
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen Hospital
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07570342
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activation in Cases of Suboptimal Fertilization PotentialART Fertility Clinics LLCNot Yet RecruitingNot Applicable
NCT07570342Not Yet Recruiting
Not Applicable
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activa...ART Fertility Clinics LLC
NCT07570628
FRAGICLIC : Implementation of a Clinical Decision Support System in Primary Care for the Screening and Assessment of Frailty in Patients Aged 65 and Over: A Real-World Prospective Cohort StudyCNGE ConseilNot Yet Recruiting
NCT07570628Not Yet Recruiting
—
FRAGICLIC : Implementation of a Clinical Decision Support System in Primary Care...CNGE Conseil
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 11 (5%)